Singapore markets open in 6 hours 17 minutes

Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
7.730.00 (0.00%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 51.37B
Enterprise value 46.44B
Trailing P/E 27.91
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.38
Price/book (mrq)1.69
Enterprise value/revenue 5.84
Enterprise value/EBITDA 20.49

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 33.34%
S&P500 52-week change 326.24%
52-week high 38.68
52-week low 35.93
50-day moving average 37.23
200-day moving average 37.22

Share statistics

Avg vol (3-month) 334.19M
Avg vol (10-day) 346.26M
Shares outstanding 56.65B
Implied shares outstanding 66.65B
Float 84.41B
% held by insiders 130.49%
% held by institutions 127.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.03
Forward annual dividend yield 40.39%
Trailing annual dividend rate 30.03
Trailing annual dividend yield 30.39%
5-year average dividend yield 4N/A
Payout ratio 410.83%
Dividend date 3N/A
Ex-dividend date 405 Jun 2024
Last split factor 218:10
Last split date 328 Sept 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 22.84%
Operating margin (ttm)28.60%

Management effectiveness

Return on assets (ttm)4.36%
Return on equity (ttm)6.07%

Income statement

Revenue (ttm)7.96B
Revenue per share (ttm)1.19
Quarterly revenue growth (yoy)-0.30%
Gross profit (ttm)N/A
EBITDA 2.38B
Net income avi to common (ttm)1.82B
Diluted EPS (ttm)0.28
Quarterly earnings growth (yoy)5.30%

Balance sheet

Total cash (mrq)4.93B
Total cash per share (mrq)0.74
Total debt (mrq)2.03M
Total debt/equity (mrq)0.01%
Current ratio (mrq)4.05
Book value per share (mrq)4.59

Cash flow statement

Operating cash flow (ttm)1.96B
Levered free cash flow (ttm)1.23B